Innovative Bioresearch Ltd is a privately held biotech company founded by Italian research scientist Jonathan Fior with the goal of bringing innovation to the field of HIV, cancer and regeneration research. The INNBC and INNBCL crypto assets were issued to expand its biomedical research, as well as to provide a direct utility as a means of payment to access on one hand all its medical products and services, and on the other to become the most widely used digital payment system used by a wide number of companies and commercial activities. INNBC, InnovativeBioresearchCoin (0xEb70bbf15Fd1c0542896A80f2aF90C8FD40a9ec5) is the original and main token issued by Innovative Bioresearch for developing its novel AIDS cure research. INNBCL, InnovativeBioresearchClassic (0x0Cc9FCCFF81252F4bd8C5c6b359B14ae2Ed851cf) is a sister coin issued at a later time for further supporting the research so it could also start cancer/regeneration research projects. Holding INNBCL makes users eligible for INNBC airdrop and bonuses.
